Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammaplasty | 6 | 2020 | 1232 | 1.080 |
Why?
|
Breast Implants | 3 | 2020 | 407 | 1.000 |
Why?
|
Free Tissue Flaps | 2 | 2023 | 331 | 0.720 |
Why?
|
Fibula | 2 | 2023 | 266 | 0.650 |
Why?
|
Breast Implantation | 2 | 2020 | 219 | 0.590 |
Why?
|
Hand | 2 | 2021 | 902 | 0.580 |
Why?
|
Hidradenitis Suppurativa | 1 | 2021 | 177 | 0.570 |
Why?
|
Scaphoid Bone | 1 | 2017 | 85 | 0.520 |
Why?
|
Nipples | 4 | 2020 | 229 | 0.510 |
Why?
|
Surgical Flaps | 4 | 2019 | 1670 | 0.500 |
Why?
|
Fractures, Ununited | 1 | 2017 | 175 | 0.490 |
Why?
|
Silicone Elastomers | 1 | 2014 | 78 | 0.470 |
Why?
|
Dental Implants | 1 | 2023 | 795 | 0.470 |
Why?
|
Bone Transplantation | 1 | 2017 | 927 | 0.390 |
Why?
|
Electric Stimulation Therapy | 1 | 2014 | 626 | 0.310 |
Why?
|
Pain, Postoperative | 2 | 2015 | 1737 | 0.280 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 84 | 0.220 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.220 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4058 | 0.220 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 174 | 0.210 |
Why?
|
Multipotent Stem Cells | 1 | 2024 | 200 | 0.210 |
Why?
|
Polydactyly | 1 | 2021 | 56 | 0.180 |
Why?
|
Coronary Artery Disease | 1 | 2019 | 6403 | 0.170 |
Why?
|
Maxilla | 1 | 2023 | 494 | 0.170 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2021 | 190 | 0.170 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2021 | 156 | 0.160 |
Why?
|
Th2 Cells | 1 | 2024 | 1056 | 0.160 |
Why?
|
Quadriceps Muscle | 1 | 2017 | 155 | 0.130 |
Why?
|
Magnetic Field Therapy | 1 | 2015 | 27 | 0.120 |
Why?
|
Hypopharynx | 1 | 2014 | 53 | 0.120 |
Why?
|
Hypersensitivity | 1 | 2024 | 1167 | 0.120 |
Why?
|
Rectus Abdominis | 1 | 2015 | 103 | 0.120 |
Why?
|
Pharyngeal Neoplasms | 1 | 2014 | 113 | 0.120 |
Why?
|
Esthetics | 1 | 2016 | 327 | 0.120 |
Why?
|
Hypertrophy | 1 | 2016 | 560 | 0.120 |
Why?
|
Postoperative Care | 1 | 2021 | 1467 | 0.120 |
Why?
|
Carcinoma, Ductal | 1 | 2014 | 97 | 0.110 |
Why?
|
Calmodulin | 1 | 2014 | 218 | 0.110 |
Why?
|
Models, Anatomic | 1 | 2017 | 683 | 0.110 |
Why?
|
Color | 1 | 2014 | 299 | 0.110 |
Why?
|
Electromagnetic Fields | 1 | 2014 | 289 | 0.100 |
Why?
|
Body Fluids | 1 | 2014 | 320 | 0.100 |
Why?
|
Surgical Wound Dehiscence | 1 | 2013 | 212 | 0.100 |
Why?
|
Tongue Neoplasms | 1 | 2014 | 183 | 0.100 |
Why?
|
Preoperative Care | 1 | 2021 | 2242 | 0.100 |
Why?
|
Exercise Test | 1 | 2019 | 2127 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1810 | 0.090 |
Why?
|
Surface Properties | 1 | 2014 | 1162 | 0.090 |
Why?
|
Pharynx | 1 | 2014 | 432 | 0.090 |
Why?
|
Laryngeal Neoplasms | 1 | 2014 | 514 | 0.090 |
Why?
|
Pyrococcus horikoshii | 1 | 2010 | 5 | 0.090 |
Why?
|
Mastectomy | 1 | 2019 | 1817 | 0.090 |
Why?
|
Amino Acid Transport System X-AG | 1 | 2010 | 39 | 0.090 |
Why?
|
Vasoconstrictor Agents | 1 | 2014 | 654 | 0.090 |
Why?
|
Postoperative Complications | 3 | 2019 | 15609 | 0.080 |
Why?
|
Treatment Outcome | 5 | 2021 | 64572 | 0.080 |
Why?
|
Interleukin-1beta | 1 | 2015 | 998 | 0.080 |
Why?
|
Glutamates | 1 | 2010 | 389 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8516 | 0.080 |
Why?
|
Mastectomy, Segmental | 1 | 2014 | 955 | 0.080 |
Why?
|
Neovascularization, Pathologic | 1 | 2019 | 2644 | 0.080 |
Why?
|
Soft Tissue Neoplasms | 1 | 2017 | 1158 | 0.080 |
Why?
|
Coronary Angiography | 1 | 2019 | 4470 | 0.070 |
Why?
|
Cells, Cultured | 2 | 2024 | 18937 | 0.070 |
Why?
|
Cicatrix | 1 | 2013 | 785 | 0.070 |
Why?
|
Humans | 17 | 2024 | 760740 | 0.070 |
Why?
|
Breast | 1 | 2016 | 1963 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2010 | 2747 | 0.060 |
Why?
|
Chronic Disease | 1 | 2021 | 9310 | 0.060 |
Why?
|
Wound Healing | 2 | 2015 | 2802 | 0.060 |
Why?
|
Sarcoma | 1 | 2017 | 1800 | 0.060 |
Why?
|
Nitric Oxide | 1 | 2014 | 2135 | 0.060 |
Why?
|
Female | 10 | 2020 | 392203 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9277 | 0.060 |
Why?
|
Pain Measurement | 1 | 2014 | 3546 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5493 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2016 | 3451 | 0.060 |
Why?
|
Double-Blind Method | 2 | 2015 | 12333 | 0.050 |
Why?
|
Software | 1 | 2017 | 4432 | 0.050 |
Why?
|
Prospective Studies | 2 | 2019 | 54364 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7403 | 0.050 |
Why?
|
Middle Aged | 7 | 2019 | 220603 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2019 | 80583 | 0.040 |
Why?
|
Limb Deformities, Congenital | 1 | 2021 | 136 | 0.040 |
Why?
|
Toes | 1 | 2021 | 209 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2019 | 20988 | 0.040 |
Why?
|
Thumb | 1 | 2021 | 232 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20077 | 0.040 |
Why?
|
Adult | 6 | 2019 | 220995 | 0.040 |
Why?
|
Mice | 2 | 2024 | 81368 | 0.030 |
Why?
|
Thigh | 1 | 2017 | 239 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10759 | 0.030 |
Why?
|
Exudates and Transudates | 1 | 2015 | 174 | 0.030 |
Why?
|
Aged | 5 | 2019 | 169092 | 0.030 |
Why?
|
Risk Factors | 2 | 2019 | 74128 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58919 | 0.030 |
Why?
|
Cutaneous Fistula | 1 | 2014 | 79 | 0.030 |
Why?
|
Pharyngeal Diseases | 1 | 2014 | 134 | 0.030 |
Why?
|
Fistula | 1 | 2014 | 212 | 0.030 |
Why?
|
Animals | 3 | 2024 | 168202 | 0.030 |
Why?
|
Organ Size | 1 | 2016 | 2252 | 0.020 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2014 | 290 | 0.020 |
Why?
|
Signal Transduction | 1 | 2014 | 23415 | 0.020 |
Why?
|
Vasoconstriction | 1 | 2014 | 592 | 0.020 |
Why?
|
United States | 1 | 2019 | 72292 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3077 | 0.020 |
Why?
|
Fluoresceins | 1 | 2010 | 235 | 0.020 |
Why?
|
Movement | 1 | 2017 | 1476 | 0.020 |
Why?
|
Carcinoma, Lobular | 1 | 2014 | 480 | 0.020 |
Why?
|
Trypsin | 1 | 2010 | 495 | 0.020 |
Why?
|
Factor Xa | 1 | 2010 | 166 | 0.020 |
Why?
|
Cytokines | 1 | 2024 | 7373 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 2014 | 791 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2010 | 489 | 0.020 |
Why?
|
Knee Joint | 1 | 2017 | 1676 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2010 | 1229 | 0.020 |
Why?
|
Recovery of Function | 1 | 2017 | 2977 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2024 | 11512 | 0.020 |
Why?
|
Graft Survival | 1 | 2017 | 3814 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2010 | 1790 | 0.020 |
Why?
|
Male | 3 | 2019 | 360402 | 0.020 |
Why?
|
Biological Transport | 1 | 2010 | 2089 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2010 | 3074 | 0.010 |
Why?
|
Cattle | 1 | 2010 | 3841 | 0.010 |
Why?
|
Reoperation | 1 | 2014 | 4300 | 0.010 |
Why?
|
Ligands | 1 | 2010 | 3268 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2010 | 1971 | 0.010 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2894 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13442 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2014 | 4021 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17630 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39062 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23974 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 41464 | 0.010 |
Why?
|
Child | 1 | 2021 | 80089 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 59191 | 0.010 |
Why?
|
Concepts
(136)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(59)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_